Epigallocatechin-3-gallate potentiates curcumin's ability to suppress uterine leiomyosarcoma cell growth and induce apoptosis (Q39393499)

11 September 2017

Epigallocatechin-3-gallate potentiates curcumin's ability to suppress uterine leiomyosarcoma cell growth and induce apoptosis (English)

1 reference

11 September 2017

0 references

0 references

1 reference

7

Nobuo Yaegashi

1 reference

11 September 2017

Akiko Kondo

1

1 reference

11 September 2017

Takashi Takeda

2

1 reference

11 September 2017

Bin Li

3

1 reference

11 September 2017

Kenji Tsuiji

4

1 reference

11 September 2017

Mari Kitamura

5

1 reference

11 September 2017

Tze Fang Wong

6

1 reference

11 September 2017

15 February 2012

1 reference

International Journal of Clinical Oncology

11 September 2017

1 reference

11 September 2017

18

1 reference

11 September 2017

3

1 reference

11 September 2017

380-388

1 reference

https://scigraph.springernature.com/pub.10.1007/s10147-012-0387-7

11 September 2017

0 references

cites work

Incidence of lymph node and ovarian metastases in leiomyosarcoma of the uterus.

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0387-7

A randomized study of adriamycin with and without dimethyl triazenoimidazole carboxamide in advanced uterine sarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0387-7

Ifosfamide and doxorubicin in the treatment of advanced leiomyosarcomas of the uterus: a Gynecologic Oncology Group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0387-7

Clinical management of uterine sarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0387-7

Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0387-7

Increased AKT S473 phosphorylation after mTORC1 inhibition is rictor dependent and does not predict tumor cell response to PI3K/mTOR inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0387-7

Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0387-7

Possible mechanisms of the cancer-preventive activities of green tea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0387-7

Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0387-7

O-methylated catechins from tea leaves inhibit multiple protein kinases in mast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0387-7

Epigallocatechin gallate (EGCG), a major component of green tea, is a dual phosphoinositide-3-kinase/mTOR inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0387-7

Curcumin and cancer: an "old-age" disease with an "age-old" solution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0387-7

Curcumin disrupts uterine leiomyosarcoma cells through AKT-mTOR pathway inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0387-7

The combination of epigallocatechin gallate and curcumin suppresses ER alpha-breast cancer cell growth in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0387-7

Curcumin inhibits prosurvival pathways in chronic lymphocytic leukemia B cells and may overcome their stromal protection in combination with EGCG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0387-7

New role of (-)-epicatechin in enhancing the induction of growth inhibition and apoptosis in human lung cancer cells by curcumin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0387-7

A receptor for green tea polyphenol EGCG

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0387-7

TLR4 signaling inhibitory pathway induced by green tea polyphenol epigallocatechin-3-gallate through 67-kDa laminin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0387-7

Laminin receptor activation inhibits endothelial tissue factor expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0387-7

Prostaglandin D2 induces heme oxygenase-1 in human retinal pigment epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0387-7

Curcumin-induced GADD153 upregulation: modulation by glutathione

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0387-7

Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0387-7

Rapamycin induces feedback activation of Akt signaling through an IGF-1R-dependent mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0387-7

Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0387-7

Apoptotic DNA fragmentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0387-7

A randomized clinical trial of adjuvant adriamycin in uterine sarcomas: a Gynecologic Oncology Group Study

21 January 2018

1 reference

12 December 2020

(-)-Epigallocatechin-3-gallate blocks the induction of nitric oxide synthase by down-regulating lipopolysaccharide-induced activity of transcription factor nuclear factor-kappaB

1 reference

12 December 2020

[Antibacterial and anti-hemolysin activities of tea catechins and their structural relatives].

1 reference

12 December 2020

Establishment of a human leiomyosarcoma cell line

1 reference

12 December 2020

Combinatorial prevention of carcinogenic risk in a model for familial colon cancer.

1 reference

12 December 2020

Mechanisms of Cancer Prevention by Tea Constituents

1 reference

12 December 2020

Effect of adjuvant chemotherapy on time to recurrence and survival of stage I uterine sarcomas

1 reference

12 December 2020

Green tea (Camellia sinensis) extract and its possible role in the prevention of cancer.

1 reference

12 December 2020

The green tea polyphenol (-)-epigallocatechin-3-gallate blocks nuclear factor-kappa B activation by inhibiting I kappa B kinase activity in the intestinal epithelial cell line IEC-6.

1 reference

12 December 2020

Uterine sarcoma: prognostic factors and treatment evaluation.

1 reference

12 December 2020

The AKT-mTOR pathway plays a critical role in the development of leiomyosarcomas

1 reference

12 December 2020

Epigallocatechin-3-gallate, a green tea-derived polyphenol, inhibits IL-1 beta-dependent proinflammatory signal transduction in cultured respiratory epithelial cells

1 reference

12 December 2020

Treatment of recurrent or advanced uterine sarcoma. A randomized trial of doxorubicin versus doxorubicin and cyclophosphamide (a phase III trial of the Gynecologic Oncology Group)

1 reference

12 December 2020

10.1007/S10147-012-0387-7

Identifiers

DOI

1 reference

11 September 2017

1 reference